Insilico Medicine Lists on Hong Kong Stock Exchange, Showing AI Drug Discovery Momentum with 2025's Largest Hong Kong Biotech IPO
HONG KONG, Dec. 30, 2025 /PRNewswire/ -- Insilico Medicine (3696.HK), a clinical-stage drug discovery and development company driven by generative artificial intelligence (AI), is successfully listed on the Hong Kong Stock Exchange today, becoming...
CICC Expands Its Global Footprint with Official Launch of DIFC Branch
DUBAI, UAE, May 15, 2025 /PRNewswire/ -- On May 15th, 2025, China International Capital Corporation Limited ("CICC"), China's leading investment bank, officially launches its branch in Dubai International Financial Centre ("DIFC"), the leading...